ReviewCurrent microbiology2026
Emerging Nanomaterials-Based Biosensors for the Clinical and Pathological Detection of E. Coli O157:H7.
Review in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The swift and accurate detection of Escherichia coli O157:H7 is vital for safeguarding public health due to the serious health risks it poses. Traditional detection methods, while effective, often face challenges such as prolonged processing times, intricate sample preparation, and reliance on specialized laboratory equipment. To address these issues, significant advancements have been made in the development of nanomaterials-based biosensors over the past two decades. These innovative technologies exploit the unique properties of nanomaterials, including their high surface area, enhanced reactivity, and capacity for rapid signal transduction. This manuscript reviews the recent advancements in biosensor technologies that utilize nanomaterials for detecting E. coli O157:H7, focusing on various strategies such as electrochemical, optical, and piezoelectric biosensors. The benefits of these methods include improved sensitivity and specificity, along with the potential for real-time monitoring in clinical settings. Additionally, the pathological implications of E. coli O157:H7 infections are discussed, emphasizing the importance of timely detection for effective clinical management.
Indexed as
Identifiers
41706197What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.